Department of General Internal Medicine, Akashi Medical Center, Hyogo, Japan.
Department of Healthcare Economics and Quality Management, Graduate School of Medicine, Kyoto University, Japan.
Hosp Pract (1995). 2023 Aug;51(3):135-140. doi: 10.1080/21548331.2023.2192574. Epub 2023 Mar 22.
In Japan, the benefits of hospitalist physician-led care after heart failure have not been sufficiently demonstrated. We evaluated quality of care by the general internal medicine hospitalist (GIM-H) system for patients after acute heart failure and compared it with care by cardiologists.
This retrospective cohort study enrolled adult patients from within a two-year period who were admitted to our institution for heart failure. Primary outcome measures were medico-economic indicators: length of hospital stay and medical costs. Secondary outcomes included readmission within 30 days of discharge, death within 30 days of admission, rate of prescription of ACEI/ARB and beta-blockers for heart failure with reduced left ventricular ejection fraction, and the percentage of patients receiving bespoke written treatment plans after discharge. This was thought to represent quality of heart failure-specific care. Outcomes between the groups were compared by adjusting for background factors using a propensity score.
We enrolled 404 patients, and 81 were assigned to each group after matching (mean age: 86 years, female: 64.2%, mean left ventricular ejection fraction: 53.2%). The GIM-H-treated group had a significantly shorter hospital stay (13.7 days vs. 21.8 days, < 0.001), a significantly lower total medical cost (618,805 JPY vs. 867,857 JPY, < 0.05) but a higher medical cost per day (48,010 JPY vs 42,813 JPY, < 0.05) than the cardiologist-treated group. Other indicators were not significantly different.
: GIM-H physicians in Japan are suggested to be useful and effective in care of patients with heart failure. The hospitalist system may positively impact the health economic outcomes of such patients.
在日本,尚未充分证明心脏病专家主导的心力衰竭治疗后的获益。我们评估了综合内科医院医师(GIM-H)系统对急性心力衰竭患者的治疗质量,并将其与心脏病专家的治疗进行了比较。
本回顾性队列研究纳入了在我院因心力衰竭住院的两年内的成年患者。主要转归指标为医疗经济学指标:住院时间和医疗费用。次要转归指标包括出院后 30 天内再入院、入院后 30 天内死亡、左心室射血分数降低的心力衰竭患者处方 ACEI/ARB 和β受体阻滞剂的比例,以及出院后接受定制书面治疗计划的患者比例。这被认为代表了心力衰竭特异性治疗的质量。使用倾向评分调整背景因素后,比较两组之间的结局。
我们纳入了 404 例患者,匹配后每组 81 例(平均年龄:86 岁,女性:64.2%,平均左心室射血分数:53.2%)。GIM-H 治疗组的住院时间明显缩短(13.7 天 vs. 21.8 天, < 0.001),总医疗费用明显降低(618805 日元 vs. 867857 日元, < 0.05),但每日医疗费用较高(48010 日元 vs. 42813 日元, < 0.05),高于心脏病专家治疗组。其他指标无显著差异。
日本的综合内科医院医师在心力衰竭患者的治疗中是有用且有效的。医院医师系统可能对这些患者的健康经济学结局产生积极影响。